NEW YORK – Single-cell proteomics firm IsoPlexis announced Tuesday an exclusive agreement with Neoline Technology to distribute IsoPlexis' products in China.
The partnership will provide Chinese customers access to the Brandford, Connecticut-based company's IsoLight platform, which enables multiplexed immunoassays at the single-cell level.